2026 - News Updates
-
As Earl Stadtman Investigator, Dr. Yano will study the etiology of upper aerodigestive tract cancers and the role of the human microbiome in these cancers.
-
As Earl Stadtman Investigator Dr. Lawrence aims to reveal how the neighborhood circumstances affect cancer risk and long-term survival rates.
-
Michael Dean, Ph.D., senior investigator in the Laboratory of Translational Genomics, retired from the National Cancer Institute (NCI) in July 2026. Dr. Dean is known for his work on germline genetic variation, somatic mutations in tumors, and the combined effect on cancer risk, progression, and response to therapy. He also investigated the genetic components of cancer health disparities in the U.S. and in Latin America.
-
Remembering Joseph F. Fraumeni, Jr., Founder of the NCI Division of Cancer Epidemiology and Genetics
A tribute to Dr. Joseph F. Fraumeni, Jr., whose discoveries in cancer genetics and epidemiology transformed cancer research and prevention.
-
Erikka Loftfield, former Earl Stadtman investigator, began a new position as leader of the Integrative Nutritional Epidemiology Group at Queensland Institute of Medical Research Berghofer in Brisbane, Australia.
-
Elizabeth K. Cahoon, Ph.D., was awarded scientific tenure by the NIH and promoted to senior investigator in the Radiation Epidemiology Branch (REB). Dr. Cahoon is an internationally recognized radiation epidemiologist whose work focuses on understanding how environmental sources of radiation exposure affect cancer risk.
-
Alisa Goldstein, senior investigator in the Clinical Genetics Branch, retired from the NCI in 2025 after 37 years of service. Dr. Goldstein is an internationally recognized expert in the genetic etiology of melanoma, chordoma, and upper gastrointestinal cancer.